IT1200967B - Compresse di naproxene e di naproxene sodicc a cessione controllata - Google Patents

Compresse di naproxene e di naproxene sodicc a cessione controllata

Info

Publication number
IT1200967B
IT1200967B IT67870/83A IT6787083A IT1200967B IT 1200967 B IT1200967 B IT 1200967B IT 67870/83 A IT67870/83 A IT 67870/83A IT 6787083 A IT6787083 A IT 6787083A IT 1200967 B IT1200967 B IT 1200967B
Authority
IT
Italy
Prior art keywords
naproxene
sodicc
tablets
sale
controlled
Prior art date
Application number
IT67870/83A
Other languages
English (en)
Other versions
IT8367870A0 (it
Inventor
Charles S Hsiao
John S Kent
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24004892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1200967(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of IT8367870A0 publication Critical patent/IT8367870A0/it
Application granted granted Critical
Publication of IT1200967B publication Critical patent/IT1200967B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
IT67870/83A 1983-06-14 1983-08-12 Compresse di naproxene e di naproxene sodicc a cessione controllata IT1200967B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/504,112 US4571333A (en) 1983-06-14 1983-06-14 Controlled release naproxen and naproxen sodium tablets

Publications (2)

Publication Number Publication Date
IT8367870A0 IT8367870A0 (it) 1983-08-12
IT1200967B true IT1200967B (it) 1989-01-27

Family

ID=24004892

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67870/83A IT1200967B (it) 1983-06-14 1983-08-12 Compresse di naproxene e di naproxene sodicc a cessione controllata

Country Status (24)

Country Link
US (2) US4571333A (it)
AT (1) AT389225B (it)
AU (1) AU552080B2 (it)
BE (1) BE899885A (it)
CA (1) CA1204671A (it)
CH (1) CH643455A5 (it)
DE (1) DE3329265A1 (it)
DK (1) DK162814C (it)
FI (1) FI83037C (it)
FR (1) FR2547498B1 (it)
GB (1) GB2141338B (it)
HK (1) HK95590A (it)
IE (1) IE55585B1 (it)
IL (1) IL69371A0 (it)
IT (1) IT1200967B (it)
LU (1) LU84962A1 (it)
MY (1) MY100439A (it)
NL (1) NL191669C (it)
NO (1) NO167001C (it)
NZ (1) NZ204708A (it)
PH (1) PH17827A (it)
SE (1) SE454565B (it)
SG (1) SG80990G (it)
ZA (1) ZA835591B (it)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061897A (en) * 1976-01-23 1977-12-06 Audrae Thykeson Heating pad
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE69301742T2 (de) * 1992-02-17 1996-08-14 Siegfried Ag Pharma Darreichungsformen mit verlaengerter Wirkstoffreigabe
IL104192A (en) * 1992-02-17 1998-01-04 Siegfried Ag Pharma Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
RU2121830C1 (ru) * 1992-09-18 1998-11-20 Яманоути Фармасьютикал Ко., ЛТД Гидрогелевый препарат с длительным высвобождением лекарства
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US6080888A (en) * 1997-01-08 2000-06-27 Albemarle Corporation Preparation of olefinic compounds and carboxylic derivatives thereof
US6096920A (en) * 1997-01-08 2000-08-01 Albemarle Corporation Preparation of carboxylic compounds and their derivatives
US5792886A (en) * 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US5859292A (en) * 1997-12-11 1999-01-12 Albemarle Corporation Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
US5874614A (en) * 1997-12-11 1999-02-23 Albemarle Corporation Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
US6638959B2 (en) 2000-01-18 2003-10-28 Albemarle Corporation Microbiological control in aqueous systems
US20050049420A1 (en) * 2000-01-18 2005-03-03 Elnagar Hassan Y. Process for producing N-halogenated organic compounds
US7579018B2 (en) * 2000-01-18 2009-08-25 Albemarle Corporation Microbiological control in aqueous systems
US6495698B1 (en) 2000-01-18 2002-12-17 Albemarle Corporation Binder-free compacted forms of 1,3-dihalo-5,5-dimethylhydantoins
US6508954B1 (en) 2000-01-18 2003-01-21 Albemarle Corporation 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
US6680070B1 (en) 2000-01-18 2004-01-20 Albemarle Corporation Particulate blends and compacted products formed therefrom, and the preparation thereof
US6565868B1 (en) 2000-01-18 2003-05-20 Albemarle Corporation Methods for microbiological control in aqueous systems
US6809205B1 (en) 2000-01-18 2004-10-26 Albemarle Corporation Process for producing N-halogenated organic compounds
US6448410B1 (en) 2000-01-18 2002-09-10 Albemarle Corporation Production of compacted biocidal agent from particulate biocidal agent without using a binder
US7371397B2 (en) * 2000-01-18 2008-05-13 Albemarle Corporation Methods for microbiological control in aqueous systems
US7999118B2 (en) * 2000-01-18 2011-08-16 Albemarle Corporation Process for producing N-halogenated hydantoins
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
US6919364B2 (en) * 2001-06-28 2005-07-19 Solution Biosciences, Inc. Microbiological control in animal processing
WO2003011033A1 (en) * 2001-06-28 2003-02-13 Solution Biosciences, Inc. Microbiological control in animal processing
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
EA200400343A1 (ru) * 2001-08-29 2004-08-26 Рэнбакси Лабораториз Лимитед Композиция с контролируемым высвобождением кларитромицина или тинидазола
WO2003031347A1 (en) * 2001-10-09 2003-04-17 Albemarle Corporation Control of biofilms in industrial water systems
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
EP1485078B1 (en) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran for the treatment of irritable bowel syndrome
US20040010024A1 (en) * 2002-07-10 2004-01-15 Howarth Jonathan N. Particulate blends and compacted products formed therefrom, and the preparation thereof
US6965035B1 (en) 2002-07-25 2005-11-15 Albemarle Corp Compacted forms of halogenated hydantoins
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228918A1 (en) * 2003-01-02 2004-11-18 Chih-Ming Chen Granule modulating hydrogel system
EP1592453A1 (en) * 2003-01-28 2005-11-09 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US7901276B2 (en) * 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
WO2005011682A1 (ja) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. 経口徐放性錠剤
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
CN101115392B (zh) * 2004-12-23 2011-05-11 雅宝公司 产肉四足动物加工中的杀微生物控制
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
BRPI0620851B1 (pt) * 2005-12-01 2016-08-23 Albemarle Corp método para controle microbiano no processo de produção de carne de animais quadrúpedes
EP2155170A2 (en) * 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
AR082189A1 (es) 2010-07-06 2012-11-21 Gruenenthal Gmbh Formas de dosificacion gastrorretentivas, procedimiento
US9415048B2 (en) * 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20120244218A1 (en) 2011-03-25 2012-09-27 Durkee Shane E Calcium supplement
CN106880614A (zh) * 2017-04-06 2017-06-23 地奥集团成都药业股份有限公司 一种萘普生缓释片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
FR2146564A5 (it) * 1971-07-19 1973-03-02 Peugeot & Renault
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets

Also Published As

Publication number Publication date
NL191669C (nl) 1996-02-05
IE55585B1 (en) 1990-11-07
ATA191084A (de) 1989-04-15
AU1801183A (en) 1984-12-20
AU552080B2 (en) 1986-05-22
CA1204671A (en) 1986-05-20
FI842400A0 (fi) 1984-06-13
SG80990G (en) 1990-11-23
FI842400A (fi) 1984-12-15
NL191669B (nl) 1995-10-02
US4803079A (en) 1989-02-07
PH17827A (en) 1985-01-07
NO167001C (no) 1991-09-25
FR2547498A1 (fr) 1984-12-21
NZ204708A (en) 1984-12-14
DE3329265C2 (it) 1991-04-11
NO167001B (no) 1991-06-17
FI83037B (fi) 1991-02-15
DK553683D0 (da) 1983-12-01
DE3329265A1 (de) 1984-12-20
GB8321757D0 (en) 1983-09-14
SE8304393L (sv) 1984-12-15
FI83037C (fi) 1991-05-27
IE831799L (en) 1984-12-14
DK162814C (da) 1992-05-04
IL69371A0 (en) 1983-11-30
DK553683A (da) 1984-12-15
GB2141338B (en) 1988-06-02
HK95590A (en) 1990-11-23
IT8367870A0 (it) 1983-08-12
AT389225B (de) 1989-11-10
MY100439A (en) 1990-09-29
FR2547498B1 (fr) 1986-06-13
SE454565B (sv) 1988-05-16
CH643455A5 (de) 1984-06-15
SE8304393D0 (sv) 1983-08-12
GB2141338A (en) 1984-12-19
ZA835591B (en) 1985-03-27
US4571333A (en) 1986-02-18
LU84962A1 (de) 1983-12-28
NO842362L (no) 1984-12-17
NL8302842A (nl) 1985-01-02
BE899885A (fr) 1984-12-12
DK162814B (da) 1991-12-16

Similar Documents

Publication Publication Date Title
IT1200967B (it) Compresse di naproxene e di naproxene sodicc a cessione controllata
DK143689D0 (da) Pakningsmateriale
ATA161188A (de) Tablettenspender
DK672689D0 (da) Mikrokapsler og granulaert vaskemiddel omfattende samme
DK233789D0 (da) Filmcoated tablet
MC2112A1 (fr) Comprime effervescent
DK64391D0 (da) Kommunikationsapparat til flere formaal
DK172084D0 (da) Lager-og udstillingssystem
ATA160785A (de) Teilchenfoermiges waschmittelprodukt
DK143082A (da) Hylde og udstillingskonstruktion
DK165399C (da) Emballage- og udstillingsaeske
DK636589D0 (da) Tetramethylpiperidyl-afsluttede triazin-baserede oligomere estere og amider
ATA160885A (de) Teilchenfoermiges waschmittelprodukt
ATA220583A (de) Tablettenspender
KR890002043U (ko) 화장품 보관 케이스
BR6701079U (pt) Embalagem reversivel
ES290808Y (es) Un rompecabezas cubico
TR24697A (tr) Indan tuerevleri
KR890022479U (ko) 간이 보관대
IT8303416V0 (it) Ciondolo portaoggetti
RO80826A2 (ro) Produs medicamentos cu actiune hepatobiliara si hepatoprotectoare
MX18769A (es) Taninos sulfatados y sus sales
KR890016269U (ko) 파렛트
DE8302336U1 (de) Schmuckanhaenger
DK285687A (da) Pakningsstrimmel

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 54

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 54, 19920311; SYNTEX PHARMACEUTICALS INTERNATION AL LIMITED

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950831